Zai Lab Limited (ZLAB)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 01:57PM EDT. Market open.
| Previous close | 16.25 |
| Open | 16.85 |
| Bid | 16.93 x 200 |
| Ask | 21.67 x 200 |
| Day's range | 16.85 - 17.36 |
| 52-week range | 13.48 - 39.50 |
| Volume | |
| Avg. volume | 635,600 |
| Market cap | 1.7B |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Zai Lab Limited's (NASDAQ:ZLAB) Profit Outlook
With the business potentially at an important milestone, we thought we'd take a closer look at Zai Lab Limited's...
- Simply Wall St.
Shareholders in Zai Lab (NASDAQ:ZLAB) are in the red if they invested three years ago
As an investor, mistakes are inevitable. But really bad investments should be rare. So take a moment to sympathize with...
- GuruFocus.com
Chief Legal Officer Edmondson Frazor Titus III Sells 10,000 Shares of Zai Lab Ltd (ZLAB)
Zai Lab Ltd (NASDAQ:ZLAB), a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for cancer, autoimmune, and infectious diseases, has reported an insider sale according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.